Detecting agglomerates within pharmaceutical formulations
Particle agglomeration can compromise the clinical efficacy of pharmaceutical products and must therefore be closely controlled. This article provides practical guidance on using automated imaging for efficient agglomerate detection.
This article provides practical guidance on using automated particle image analysis to detect agglomerates in pharmaceutical formulations. Particle agglomeration has the potential to compromise clinical efficacy and must therefore be closely monitored and controlled during manufacture. Experimental data illustrate different strategies for the detection of agglomerates on the basis of size, shape and, where necessary, chemical identification.
